The recent U.S. Food and Drug Administration approval for Eli Lilly and Co.'s Omvoh, a new therapy to treat Chron's disease ...
A weekly programme that illuminates the mysteries and challenges the controversies behind the science that's changing our world.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback